Aditya Birla Fashion: 4 broker calls, targets up to ₹127
Aditya Birla Fashion & Retail Ltd
ABFRL
Ask AI
What changed in ABFRL coverage
Aditya Birla Fashion and Retail Ltd (ABFRL) drew fresh brokerage commentary after the company’s Q4 results, with houses taking different views on risk and upside. The set of notes cited a mixed stance from Morgan Stanley, Motilal Oswal, Emkay and Nuvama Research. The divergence is visible in target prices as well, ranging from ₹65 to ₹127 in the latest set of calls mentioned.
While the coverage referenced a net loss in Q4, at least one global brokerage kept a positive stance on the stock. At the same time, other firms either stayed cautious or made smaller upward adjustments to their targets.
Morgan Stanley: Overweight, target ₹127
Morgan Stanley maintained an Overweight rating on ABFRL with a target price of ₹127. The brokerage’s stance was described as bullish even though the company reported a net loss in its Q4 results.
The repeated references in the provided text underline that Morgan Stanley’s view was not a one-off mention in the coverage. The target of ₹127 implies a materially higher valuation than the trading price cited in the same report.
Motilal Oswal: Neutral, target cut to ₹65
Motilal Oswal maintained a Neutral rating. Unlike Morgan Stanley, Motilal Oswal cut its target price to ₹65 from ₹70, as stated in the article data.
A target cut alongside a neutral stance typically signals that the brokerage sees limited near-term upside at the time of publishing, even if it is not recommending an outright negative view. The data provided does not include the detailed rationale beyond the rating and target revision.
Emkay: Add, target raised to ₹75
Emkay maintained an Add rating on ABFRL. The firm raised its target price to ₹75 from ₹70.
Among the four brokerages listed, Emkay was the only one explicitly noted as raising its target while also keeping a constructive rating. The change also highlights how different analysts may interpret the same quarterly outcome differently, depending on what they focus on.
Nuvama Research: Hold, target cut to ₹71
Nuvama Research maintained a Hold rating. The firm cut its target price to ₹71 from ₹70, as written in the supplied text.
The direction of the change (a cut) conflicts with the target move shown (₹71 from ₹70). Since both values are explicitly stated, the article records the update exactly as provided, without assuming which one is a typographical error.
ABFRL share price at the time of the report
The report provided a specific market snapshot for ABFRL during trading hours. At 11:32 AM, ABFRL shares were trading 2.08% lower at ₹66.06, compared with the previous close of ₹67.46.
This price point matters because it frames how much upside or downside each brokerage target implies relative to the prevailing market price at that moment.
Key brokerage calls and targets (as cited)
Analyst recommendation widgets referenced in the text
Beyond the four-broker comparison, the provided material also included a separate “mean recommendation” snapshot. It showed HOLD as the current mean recommendation by 15 analysts, presented alongside a recommendation distribution scale (Strong Sell to Strong Buy).
In the same “Share Recommendations” panel, examples were listed with targets and organisations, including HDFC Securities (target ₹235) and Motilal Oswal Financial Services (target ₹205), with ratings displayed as SELL and NEUTRAL respectively in that snippet. The text does not provide dates or context for these particular entries, so they are best read as an additional market-data widget rather than part of the four-broker update.
Other brokerage targets mentioned in the market coverage excerpts
The supplied content also referenced several other brokerage notes and targets that appear in broader market coverage around ABFRL. These include:
- CLSA retaining an Underperform rating with a target price of ₹58.
- Jefferies maintaining a Buy rating with a target price of ₹100 in multiple excerpts.
- References to Jefferies initiating coverage with a Buy rating and a target price of ₹315.
- References to Citi maintaining a Sell rating with a target price of ₹260.
- A separate mention of Morgan Stanley reiterating an Underweight rating with a target price of ₹271.
These excerpts were included in the provided text but were not tied to the same framing as the “four brokerages” comparison. Because the dates and contexts are not specified, they should not be assumed to be part of one single event window.
Why the mixed stance matters for investors
The latest set of four calls shows how ABFRL sits in a zone where analysts can defend different conclusions at the same time. On one end, Morgan Stanley’s ₹127 target paired with an Overweight rating indicates it sees meaningful potential upside. On the other, Motilal Oswal’s target cut to ₹65 and a neutral stance suggest a more conservative view around valuation and near-term visibility.
For investors, the practical takeaway from this type of coverage is not the existence of a single “right” target, but the range of expectations and the dispersion in recommendations. The report’s trading snapshot (₹66.06 at 11:32 AM, down 2.08%) places the targets in context, showing that some estimates sit close to the market price, while others imply a much larger gap.
Conclusion
ABFRL remains under active brokerage coverage, with Morgan Stanley, Motilal Oswal, Emkay and Nuvama Research presenting a spread of ratings from Overweight to Hold and targets from ₹65 to ₹127. The stock was trading at ₹66.06 at the time cited in the report. Further clarity for the market is likely to come from subsequent management commentary and follow-up brokerage notes as more quarterly data and execution updates are digested.
Frequently Asked Questions
Did your stocks survive the war?
See what broke. See what stood.
Live Q4 Earnings Tracker